Results 181 to 190 of about 334,593 (294)

Embolic Agent Selection and Outcomes in Renal Angiomyolipoma Embolisation

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Purpose To evaluate whether embolic agent selection influences outcomes following selective arterial embolisation (SAE) of renal angiomyolipomas (r‐AMLs) and to assess procedural safety and effects on renal function. Materials and Methods A retrospective observational study was performed of all r‐AML SAEs undertaken at a tertiary institution ...
Ross O'Shea, Himanshu Pendse, Kevin Ho, Hasan Hasan, Ross Vander Wal, Matthys Van Wyk, Jonathan Tibballs, Gurjeet Dulku   +7 more
wiley   +1 more source

RGX-019-MMAE inhibits leukemia progression by targeting MER proto-oncogene tyrosine kinase (MERTK) in acute myeloid leukemia. [PDF]

J Exp Clin Cancer Res
Tyagi A, Siddiqui M, Eckstrom A, Kurth I, Takeda S, Sharma P, Borthakur G, Yuan B, Abbas HA, Anand V, Borgman J, Kornblau S, Maiti A, Battula VL.   +13 more
europepmc   +1 more source

AML / MDS [PDF]

Bone Marrow Transplantation, 2002
openaire   +1 more source

The prevalence of cannabidiol (CBD) use in North America and Europe: A meta‐analysis

Addiction, EarlyView.
Abstract Background and aims The global cannabidiol (CBD) market has expanded in recent years. Several studies suggest CBD use, whether for medical or recreational purposes, is on the rise; however, no systematic assessments of its prevalence have been conducted so far. This meta‐analysis aimed to estimate the prevalence of CBD use in North America and
Sara Weidberg, Clara Iza‐Fernández, Layla Alemán‐Moussa, Andrea Krotter, Alba González‐Roz   +4 more
wiley   +1 more source

TIM-3 in AML: pathogenic roles and therapeutic targetability. [PDF]

Clin Exp Med
Zhong L, Soleimani Samarkhazan H.
europepmc   +1 more source

Myeloablative Busulfan, Fludarabine and Melphalan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Childhood Myeloid Malignancy

Asia-Pacific Journal of Clinical Oncology, EarlyView.
We report our single‐center experience of transplant outcomes with a busulfan, fludarabine and melphalan‐based conditioning regimen for children < 18 years of age. The regimen was shown to be well tolerated and effective for heavily pretreated children with high‐risk myeloid malignancies prior to allogeneic hematopoietic stem cell transplant.
Mayank Dhamija, Fiona Kerr, Hazel Gough, Johnathan Soggee, Laurence C. Cheung, Rishi S. Kotecha, Shanti Ramachandran   +6 more
wiley   +1 more source

Measurable residual disease testing in acute myeloid leukemia: current state, foundational models, and tools for future development. [PDF]

Cancer Metastasis Rev
Van Galen J, Willis SD, Bains A, Small SH.   +3 more
europepmc   +1 more source

BRD9 inhibition as potential treatment option for testicular germ cell tumors

Andrology, EarlyView.
Abstract Background Testicular germ cell tumors (TGCT) are the predominant tumor in younger males. Usually, 5‐year survival rates are quite high, but 15–20% of patients with metastatic non‐seminomas are resistant to standard cisplatin‐based therapy.
Aylin Hansen, Christine Sanders, Florian Fronhoffs, Kai Funke, Glen Kristiansen, Hubert Schorle   +5 more
wiley   +1 more source

Reciprocal Clonal Dynamics of Independent <i>FLT3</i> D835V-Positive Acute Myeloid Leukemia and Chronic Myeloid Leukemia With Gilteritinib. [PDF]

EJHaem
Osone K, Katagiri S, Chi S, Minami Y, Gotoh A, Akahane D.   +5 more
europepmc   +1 more source

The Functional Role and Molecular Characterization of the Therapeutic Target CLDN6 in Germ Cell Tumors

Andrology, EarlyView.
ABSTRACT Background The tight junction protein CLDN6 has been identified as a cancer‐associated cell surface marker that is rarely expressed in healthy tissues. In testicular germ cell tumors (GCT), CLDN6 is particularly detectable in seminomas, embryonal carcinomas, and choriocarcinomas.
Jule Zwick, Margaretha A. Skowron, Gereon Poschmann, Patrick Petzsch, Ann Kathrin Bergmann, Kai Stühler, Jochen Hecht, Daniel Nettersheim   +7 more
wiley   +1 more source